ALVAP Fundamental Analysis - KUMULUS VAPE

Fundamental Rating

Taking everything into account, ALVAP scores 6 out of 10 in our fundamental rating. ALVAP was compared to 59 industry peers in the Specialty Retail industry. ALVAP has an excellent financial health rating, but there are some minor concerns on its profitability. ALVAP has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally ALVAP also has an excellent dividend rating. These ratings could make ALVAP a good candidate for dividend investing.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALVAP had positive earnings in the past year.

In the past year ALVAP has reported a negative cash flow from operations.

ALVAP had positive earnings in each of the past 5 years.

In the past 5 years ALVAP reported 4 times negative operating cash flow.

1.2 Ratios

ALVAP has a better Return On Assets (9.80%) than 83.05% of its industry peers.

ALVAP's Return On Equity of 16.02% is fine compared to the rest of the industry. ALVAP outperforms 72.88% of its industry peers.

ALVAP's Return On Invested Capital of 12.74% is fine compared to the rest of the industry. ALVAP outperforms 79.66% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for ALVAP is above the industry average of 11.42%.

		Industry Rank	Sector Rank
ROA	9.8%
ROE	16.02%
ROIC	12.74%

ROA(3y)9.89%

ROA(5y)10.27%

ROE(3y)16.02%

ROE(5y)15.99%

ROIC(3y)13.64%

ROIC(5y)14.38%

1.3 Margins

ALVAP has a better Profit Margin (4.35%) than 71.19% of its industry peers.

In the last couple of years the Profit Margin of ALVAP has grown nicely.

The Operating Margin of ALVAP (5.89%) is better than 67.80% of its industry peers.

In the last couple of years the Operating Margin of ALVAP has grown nicely.

ALVAP has a Gross Margin of 23.53%. This is in the lower half of the industry: ALVAP underperforms 72.88% of its industry peers.

ALVAP's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	5.89%
PM (TTM)	4.35%
GM	23.53%

OM growth 3Y0.64%

OM growth 5Y19.19%

PM growth 3Y4.02%

PM growth 5Y42.75%

GM growth 3Y5.68%

GM growth 5Y0.12%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALVAP is creating value.

ALVAP has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for ALVAP has been increased compared to 5 years ago.

The debt/assets ratio for ALVAP has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 4.55 indicates that ALVAP is not in any danger for bankruptcy at the moment.

With an excellent Altman-Z score value of 4.55, ALVAP belongs to the best of the industry, outperforming 89.83% of the companies in the same industry.

ALVAP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.

ALVAP's Debt to Equity ratio of 0.21 is amongst the best of the industry. ALVAP outperforms 83.05% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.21
Debt/FCF	N/A
Altman-Z	4.55

ROIC/WACC1.85

WACC6.88%

2.3 Liquidity

A Current Ratio of 3.30 indicates that ALVAP has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 3.30, ALVAP belongs to the top of the industry, outperforming 93.22% of the companies in the same industry.

ALVAP has a Quick Ratio of 1.76. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.76, ALVAP belongs to the top of the industry, outperforming 93.22% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.3
Quick Ratio	1.76

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALVAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.52%.

The Earnings Per Share has been growing by 97.48% on average over the past years. This is a very strong growth

ALVAP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.12%.

ALVAP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.89% yearly.

EPS 1Y (TTM)-21.52%

EPS 3Y20.5%

EPS 5Y97.48%

EPS Q2Q%-23.21%

Revenue 1Y (TTM)-34.12%

Revenue growth 3Y20.74%

Revenue growth 5Y41.89%

Sales Q2Q%-51.16%

3.2 Future

Based on estimates for the next years, ALVAP will show a decrease in Earnings Per Share. The EPS will decrease by -1.02% on average per year.

ALVAP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.11% yearly.

EPS Next Y-34.55%

EPS Next 2Y-4.02%

EPS Next 3Y-1.02%

EPS Next 5YN/A

Revenue Next Year-6.25%

Revenue Next 2Y-0.99%

Revenue Next 3Y-0.11%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.99, which indicates a rather cheap valuation of ALVAP.

Based on the Price/Earnings ratio, ALVAP is valued cheaply inside the industry as 98.31% of the companies are valued more expensively.

ALVAP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.25.

Based on the Price/Forward Earnings ratio of 7.26, the valuation of ALVAP can be described as very cheap.

Based on the Price/Forward Earnings ratio, ALVAP is valued cheaply inside the industry as 89.83% of the companies are valued more expensively.

The average S&P500 Price/Forward Earnings ratio is at 23.98. ALVAP is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	4.99
Fwd PE	7.26

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 96.61% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2.62

4.3 Compensation for Growth

ALVAP has a very decent profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.05

EPS Next 2Y-4.02%

EPS Next 3Y-1.02%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.15%, ALVAP is a good candidate for dividend investing.

ALVAP's Dividend Yield is rather good when compared to the industry average which is at 1.34. ALVAP pays more dividend than 91.53% of the companies in the same industry.

ALVAP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.

		Industry Rank	Sector Rank
Dividend Yield	4.15%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years1

Div Non Decr Years2

5.3 Sustainability

17.40% of the earnings are spent on dividend by ALVAP. This is a low number and sustainable payout ratio.

DP17.4%

EPS Next 2Y-4.02%

EPS Next 3Y-1.02%

More info and screens

Find the best dividend stocks

Show peers with best dividend

KUMULUS VAPE

EPA:ALVAP (1/12/2026, 7:00:00 PM)

4.04

-0.1 (-2.42%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners36.98%

Ins Owner ChangeN/A

Market Cap12.40M

Revenue(TTM)60.68M

Net Income(TTM)2.64M

Analysts86.67

Price Target7.04 (74.26%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	4.15%

Yearly Dividend0.15

Dividend Growth(5Y)N/A

DP17.4%

Div Incr Years1

Div Non Decr Years2

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-4.17%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)25.58%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	4.99
Fwd PE	7.26
P/S	0.2
P/FCF	N/A
P/OCF	N/A
P/B	0.75
P/tB	0.93
EV/EBITDA	2.62

EPS(TTM)0.81

EY20.05%

EPS(NY)0.56

Fwd EY13.77%

FCF(TTM)-0.47

FCFYN/A

OCF(TTM)-0.36

OCFYN/A

SpS19.77

BVpS5.37

TBVpS4.36

PEG (NY)N/A

PEG (5Y)0.05

Graham Number9.89

Profitability

		Industry Rank	Sector Rank
ROA	9.8%
ROE	16.02%
ROCE	17.82%
ROIC	12.74%
ROICexc	17.68%
ROICexgc	22.48%
OM	5.89%
PM (TTM)	4.35%
GM	23.53%
FCFM	N/A

ROA(3y)9.89%

ROA(5y)10.27%

ROE(3y)16.02%

ROE(5y)15.99%

ROIC(3y)13.64%

ROIC(5y)14.38%

ROICexc(3y)17.75%

ROICexc(5y)21.73%

ROICexgc(3y)22.02%

ROICexgc(5y)24.77%

ROCE(3y)19.12%

ROCE(5y)20.26%

ROICexgc growth 3Y1.55%

ROICexgc growth 5Y9.12%

ROICexc growth 3Y-5.62%

ROICexc growth 5Y6.22%

OM growth 3Y0.64%

OM growth 5Y19.19%

PM growth 3Y4.02%

PM growth 5Y42.75%

GM growth 3Y5.68%

GM growth 5Y0.12%

F-Score3

Asset Turnover2.25

Health

		Industry Rank	Sector Rank
Debt/Equity	0.21
Debt/FCF	N/A
Debt/EBITDA	0.82
Cap/Depr	57.64%
Cap/Sales	0.57%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.3
Quick Ratio	1.76
Altman-Z	4.55

F-Score3

WACC6.88%

ROIC/WACC1.85

Cap/Depr(3y)181.05%

Cap/Depr(5y)N/A

Cap/Sales(3y)0.97%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-21.52%

EPS 3Y20.5%

EPS 5Y97.48%

EPS Q2Q%-23.21%

EPS Next Y-34.55%

EPS Next 2Y-4.02%

EPS Next 3Y-1.02%

EPS Next 5YN/A

Revenue 1Y (TTM)-34.12%

Revenue growth 3Y20.74%

Revenue growth 5Y41.89%

Sales Q2Q%-51.16%

Revenue Next Year-6.25%

Revenue Next 2Y-0.99%

Revenue Next 3Y-0.11%

Revenue Next 5YN/A

EBIT growth 1Y-24.22%

EBIT growth 3Y21.51%

EBIT growth 5Y69.12%

EBIT Next Year-5.88%

EBIT Next 3Y3.78%

EBIT Next 5YN/A

FCF growth 1Y-124.36%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-117.39%

OCF growth 3YN/A

OCF growth 5YN/A

KUMULUS VAPE / ALVAP.PA FAQ

What is the fundamental rating for ALVAP stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALVAP.PA.

What is the valuation status of KUMULUS VAPE (ALVAP.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to KUMULUS VAPE (ALVAP.PA). This can be considered as Fairly Valued.

Can you provide the profitability details for KUMULUS VAPE?

KUMULUS VAPE (ALVAP.PA) has a profitability rating of 6 / 10.

What are the PE and PB ratios of KUMULUS VAPE (ALVAP.PA) stock?

The Price/Earnings (PE) ratio for KUMULUS VAPE (ALVAP.PA) is 4.99 and the Price/Book (PB) ratio is 0.75.

Can you provide the financial health for ALVAP stock?

The financial health rating of KUMULUS VAPE (ALVAP.PA) is 7 / 10.

KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

KUMULUS VAPE / ALVAP.PA FAQ

What is the fundamental rating for ALVAP stock?

What is the valuation status of KUMULUS VAPE (ALVAP.PA) stock?

Can you provide the profitability details for KUMULUS VAPE?

What are the PE and PB ratios of KUMULUS VAPE (ALVAP.PA) stock?

Can you provide the financial health for ALVAP stock?